CIK 0001619856
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453728228
- Phone
- +1 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- 4 Open-market sale Chief Scientific Officer sold 3,564 shares at $1.35 ($4,811)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 17,360 shares at $1.42 ($24,651)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award VP of Finance and Controller acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 33,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 33,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 33,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 118,700 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 33,000 shares (grant or award)
Page 2 of 7 · 125 filings